About Ostic Pharma
Ostic Pharma is a company based in Mumbai (India) founded in 2019 by Vinay Saini and Kusum Saini. Ostic Pharma has raised $26.35 thousand across 1 funding round from investors including SINE. Ostic Pharma operates in a competitive market with competitors including Souzhou Ribo Life Science, Senzo, Hememics Biotechnologies, PathoQuest and Quantalife, among others.
- Headquarter Mumbai, India
- Founders Vinay Saini, Kusum Saini
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Ostic Pharma Private Limited
- Date of Incorporation 06 Nov, 2015
- Jurisdiction Mumbai, Maharashtra, India
-
Annual Revenue
Not available
-
Net Profit
-$9.91 (USD)0as on Mar 31, 2017
-
EBITDA
-$9.91 (USD)0as on Mar 31, 2017
-
Total Equity Funding
$26.35 K (USD)
in 1 rounds
-
Latest Funding Round
$26.35 K (USD), Seed
Apr 26, 2020
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Ostic Pharma
Ostic Pharma has successfully raised a total of $26.35K through 1 strategic funding round. The most recent funding activity was a Seed round of $26.35 thousand completed in April 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Ostic Pharma
Ostic Pharma has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include SINE.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Sector-agnostic startups are accelerated by SINE, backed by IIT Bombay.
|
Locked | Locked | Locked |
Investor details for Ostic Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Ostic Pharma
Investment portfolio details for Ostic Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Ostic Pharma
Detailed financials for Ostic Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ostic Pharma Comparisons
Peer comparison for Ostic Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Ostic Pharma
Ostic Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Souzhou Ribo Life Science, Senzo, Hememics Biotechnologies, PathoQuest and Quantalife, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Nucleic acid drugs are developed via RNA interference technology.
|
|
| Locked | Locked | Locked |
Point-of-care diagnostic devices for infectious diseases are developed.
|
|
| Locked | Locked | Locked |
Biopreservation platform for mammalian cells and biologics is developed.
|
|
| Locked | Locked | Locked |
Next-generation sequencing is provided for microbiology testing applications.
|
|
| Locked | Locked | Locked |
Provide tools that accelerate new strategies for the diagnosis and treatment of inherited disorders, cancer, and infectious disease.
|
|
| Locked | Locked | Locked |
Sequencing-based platform for microorganism detection in patients is developed.
|
Detailed competitors of Ostic Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ostic Pharma
Complete news archive for Ostic Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ostic Pharma
Ostic Pharma was founded in 2019 and raised its 1st funding round 1 year after it was founded.
Ostic Pharma is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Ostic Pharma is a funded company, having raised a total of $26.35K across 1 funding round to date.
Ostic Pharma was established in 2019 in Mumbai, India, within the healthcare diagnostics sector. In-vitro diagnostic tests aimed at detecting infectious diseases are developed by the company. Rapid test kits for conditions including HIV, Syphilis, Hepatitis B and C, Pregnancy, COVID-19, Dengue, and Malaria are offered to support medical diagnostics in various settings. Operations are centered on producing these accessible tools for global health needs.
Ostic Pharma's top competitors include Souzhou Ribo Life Science, Quantalife and Senzo.
Ostic Pharma has 1 investor. Key investors include SINE.